PIEZO1 and airway hyperresponsiveness: Recent studies have indicated that inhibiting Piezo1 signaling pathways can partially alleviate airway hyperresponsiveness in animal models, suggesting that Piezo1 may be a new target for treating diseases with airway hyperreactivity (Ni et al., 2024; Luo M. et al., 2023).